Articles > Popular publications > PR Newswire press releases > January-March 1999 > Monday, March 1

Article: Immunex Advances NUVANCE(TM) to Phase II Clinical Trials in People With Asthma.

Article from:
PR Newswire
Article date:
March 1, 1999
Copyright

Positive Data From the First Once-a-Week Multi-Dose Trial of NUVANCE

Represents an Entirely New Investigational Approach to Treating Asthma

SEATTLE, March 1 /PRNewswire/ -- Expanded clinical trials with NUVANCE(TM) (IL-4 receptor) for the long-term control of asthma are planned to start in the second quarter of 1999, Immunex Corporation (Nasdaq: IMNX) announced today. The company expedited its development of NUVANCE based on results of the first multi-dose trial of the drug.

This placebo-controlled safety trial (Phase I/II) of NUVANCE in 62 adults with moderate persistent asthma determined that the drug was well-tolerated for up to 12 weeks of ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Magainin Pharmaceuticals Announces Additional Preclinical Data ...
PR Newswire;  November 24, 1998 ;     700+ words ... ... data demonstrated the role of IL-9 in mediating asthma in transgenic mice that overproduce ... Data Supporting the Role of IL-9 in Asthma Magainin announced on September ... the human IL-9 receptor (IL-9R) to asthma. These publications highlighted ...

Article: Genaera Announces Publication Demonstrating Increased IL-9 ...
PR Newswire;  March 17, 2004 ;     700+ words ... ... supports the relationship between IL-9 and early asthma changes such as BHR and bronchial ... Inc. to co-develop an IL-9 product for asthma. This alliance provided Genaera ... highlighting the central role of IL-9 in asthma, demonstrate its contribution ...

Article: Study: Increased IL-9 related to early asthma ...
Drug Week;  April 16, 2004 ;     700+ words ... ... supports the relationship between IL-9 and early asthma changes such as BHR and bronchial ... MedImmune, Inc., to codevelop an IL-9 product for asthma. This alliance provided Genaera ... highlighting the central role of IL-9 in asthma, demonstrate its contribution ...

Article: Protein Design Labs Begins Phase II Study Of Humanized ...
PR Newswire;  October 9, 2001 ;     700+ words ... ... important mediator of asthma and allergic diseases. Blockade of IL-4 could potentially ... the development of asthma. GSK and PDL's humanized anti-IL-4 antibody is a high ... the potential role of IL-4 in asthma, therapeutic strategies ...

Article: IL-4 Receptor Is Effective in Persistent Asthma.
Immunotherapy Weekly;  April 2, 2000 ;     666 words ... ... receiving the highest dose of IL-4R experienced asthma control compared to those ... use, patients in the 3 mg IL-4R group experienced continued asthma control over the treatment ... the effective treatment of asthma. IL-4R was determined to be ...

Article: Phase II Study Of Humanized Anti-IL-4 Antibody ...
Immunotherapy Weekly;  November 7, 2001 ;     700+ words ... ... antibody to interleukin-4 (IL-4) in asthma. The randomized, double ... important in the development of asthma. The humanized anti-IL-4 antibody is a high-affinity ... Given the potential role of IL-4 in asthma, therapeutic strategies focusing ...

Article: PATHWAY TARGETED FOR ASTHMA MAGAININ, GENENTECH SIGN $35M ...
BIOWORLD Today;  January 8, 1999 ;     700+ words ... ... are also targets beyond IL-9 in our asthma gene database we may pursue ... Mouse Studies Suggest IL-9's Link To Asthma Risk Asthma cuts off ... marker located near the IL-9 receptor and the presence of asthma and/or BHR. Magainin ...

Article: MEDIMMUNE, GENAERA COLLABORATE ON IL-9 THERAPEUTICS FOR ...
BIOWORLD Today;  April 23, 2001 ;     700+ words ... ... therapeutics for the treatment of asthma and other respiratory diseases ... foundations in respiratory disease." IL-9 is an exciting target, he ... diseases that may be mediated by IL-9, Genaera said, including 17 million asthma sufferers, 35 million individuals ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives